These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1238 related articles for article (PubMed ID: 32719094)

  • 41. Development and validation of a hypoxia-related gene pair signature to predict overall survival in head and neck squamous cell carcinoma.
    Ding Z; Li H; Yu D
    Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):3973-3983. PubMed ID: 33449166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of macrophages in head and neck squamous cell carcinoma and development of MRG-based risk signature.
    Liu L; Liu Q
    Sci Rep; 2024 Apr; 14(1):9914. PubMed ID: 38688945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and Validation of an ADME-Related Gene Signature for Survival, Treatment Outcome and Immune Cell Infiltration in Head and Neck Squamous Cell Carcinoma.
    Tang X; Li R; Wu D; Wang Y; Zhao F; Lv R; Wen X
    Front Immunol; 2022; 13():905635. PubMed ID: 35874705
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    Wei Z; Shen Y; Zhou C; Cao Y; Deng H; Shen Z
    Bioengineered; 2022 May; 13(5):13784-13800. PubMed ID: 35712757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.
    Zhang L; Li B; Peng Y; Wu F; Li Q; Lin Z; Xie S; Xiao L; Lin X; Ou Z; Cai T; Rong H; Fan S; Li J
    Oral Oncol; 2020 Nov; 110():104943. PubMed ID: 32919362
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma.
    Yang F; Zhou LQ; Yang HW; Wang YJ
    Front Genet; 2022; 13():927614. PubMed ID: 36092911
    [No Abstract]   [Full Text] [Related]  

  • 47. Identification and Validation of 17-lncRNA Related to Regulatory T Cell Heterogeneity as a Prognostic Signature for Head and Neck Squamous Cell Carcinoma.
    Sun Q; Li Y; Yang X; Wu X; Liu Z; Mou Y; Song X
    Front Immunol; 2021; 12():782216. PubMed ID: 34880875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis.
    Qiang W; Dai Y; Xing X; Sun X
    Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma.
    Li C; Wu ZH; Yuan K
    Dis Markers; 2020; 2020():8899337. PubMed ID: 33133307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic Profiling of Immune Risk Model to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.
    Liu X; Chen J; Lu W; Zeng Z; Li J; Jiang X; Gao Y; Gong Y; Wu Q; Xie C
    Front Genet; 2020; 11():576566. PubMed ID: 33193693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic impact of the immune signature in head and neck squamous cell carcinoma.
    Baysal H; Siozopoulou V; Zaryouh H; Hermans C; Lau HW; Lambrechts H; Fransen E; De Pauw I; Jacobs J; Peeters M; Pauwels P; Vermorken JB; Smits E; Lardon F; De Waele J; Wouters A
    Front Immunol; 2022; 13():1001161. PubMed ID: 36268020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inflammatory response-related genes predict prognosis in patients with HNSCC.
    Jing SL; Afshari K; Guo ZC
    Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
    Mao R; Chen Y; Xiong L; Liu Y; Zhang T
    Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Construction and validation of a prognostic signature based on seven endoplasmic reticulum stress-related lncRNAs for patients with head and neck squamous cell carcinoma.
    Zhou M; Li H; Hu J; Zhou T; Zhou L; Li Y
    Sci Rep; 2023 Dec; 13(1):22414. PubMed ID: 38104177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent-free survival in head and neck squamous cell carcinoma.
    Li Q; Shen Z; Wu Z; Shen Y; Deng H; Zhou C; Liu H
    J Clin Lab Anal; 2020 Mar; 34(3):e23107. PubMed ID: 31782831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
    Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G
    J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Chen F; Gong X; Xia M; Yu F; Wu J; Yu C; Li J
    Front Oncol; 2022; 12():857994. PubMed ID: 35619896
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Metabolic Gene Signature to Predict Overall Survival in Head and Neck Squamous Cell Carcinoma.
    Wu ZH; Tang Y; Zhou Y
    Mediators Inflamm; 2020; 2020():6716908. PubMed ID: 33456371
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma.
    Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C
    J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.